OpenAlex
PricingAboutJobs
Log inGet started
Work

Optimal long-term antithrombotic treatment of patients with stable coronary artery disease and atrial fibrillation: “OLTAT registry”

HTML

Year: 2018
Type: article
Study design: Observational Study
Source: International Journal of Cardiology
DOI: 10.1016/j.ijcard.2018.03.018
Authors: Q. Fischer, J.L. Georges, C. Le Feuvre, A. Sharma, N. Hammoudi, E. Berman, S. Cohen, I. Jolivet, J. Silvain, G. Helft
Institutions: Pitié-Salpêtrière Hospital, Hôpital André Mignot, Centre Hospitalier de Versailles, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, State University of New York, SUNY Downstate Health Sciences University, Inserm, Fondation pour l’innovation en Cadiométabolisme et Nutrition
Language: English

Topic: Atrial Fibrillation Management and Outcomes
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: stable coronary artery disease, atrial fibrillation, antithrombotic therapy, oral anticoagulation, antiplatelet therapy, vitamin K antagonists, direct oral anticoagulants, major adverse cardiac and cerebrovascular events, bleeding complications, mortality, dual antiplatelet therapy, propensity score matching, CHA2DS2-VASc score
SDG: Good health and well-being

Open Access status: closed

Funders: Boehringer Ingelheim, Eli Lilly and Company, Gilead Sciences, Fondation de France
OpenAlex ID: W2804367129
FWCI: 2.457
Cites: 23
Cited by: 25
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms